These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. Tyagi N, Kandel M, Munjal C, Qipshidze N, Vacek JC, Pushpakumar SB, Metreveli N, Tyagi SC. J Orthop Res; 2011 Oct; 29(10):1511-6. PubMed ID: 21469179 [Abstract] [Full Text] [Related]
10. Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. Jacobi J, Maas R, Cordasic N, Koch K, Schmieder RE, Böger RH, Hilgers KF. Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H1058-66. PubMed ID: 18156199 [Abstract] [Full Text] [Related]
11. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension. Savoia C, Arrabito E, Parente R, Nicoletti C, Madaro L, Battistoni A, Filippini A, Steckelings UM, Touyz RM, Volpe M. Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664 [Abstract] [Full Text] [Related]
12. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice. Ovechkin AV, Tyagi N, Sen U, Lominadze D, Steed MM, Moshal KS, Tyagi SC. Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L905-11. PubMed ID: 16815886 [Abstract] [Full Text] [Related]
13. Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model. Tyagi N, Moshal KS, Lominadze D, Ovechkin AV, Tyagi SC. Can J Physiol Pharmacol; 2005 Jul; 83(7):583-94. PubMed ID: 16091784 [Abstract] [Full Text] [Related]
14. Low doses of folic acid can reduce hyperhomocysteinemia-induced glomerular injury in spontaneously hypertensive rats. Gao N, Zhang Y, Lei L, Li L, Cao P, Zhao X, Lin L, Xu R. Hypertens Res; 2020 Nov; 43(11):1182-1191. PubMed ID: 32439914 [Abstract] [Full Text] [Related]
15. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. Am J Hypertens; 2002 Feb; 15(2 Pt 1):157-63. PubMed ID: 11863251 [Abstract] [Full Text] [Related]
16. Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats. Cao L, Lou X, Zou Z, Mou N, Wu W, Huang X, Tan H. Microvasc Res; 2013 Sep; 89():146-52. PubMed ID: 23859838 [Abstract] [Full Text] [Related]
17. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. Tyagi N, Gillespie W, Vacek JC, Sen U, Tyagi SC, Lominadze D. J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943 [Abstract] [Full Text] [Related]
18. GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemia. Shastry S, Moning L, Tyagi N, Steed M, Tyagi SC. J Cell Physiol; 2005 Dec; 205(3):422-7. PubMed ID: 15895389 [Abstract] [Full Text] [Related]
19. [Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients]. Wu CJ, Wang L, Li X, Wang CX, Ma JP, Xia XS. Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1003-8. PubMed ID: 23363713 [Abstract] [Full Text] [Related]
20. Epigenetic regulation of aortic remodeling in hyperhomocysteinemia. Narayanan N, Pushpakumar SB, Givvimani S, Kundu S, Metreveli N, James D, Bratcher AP, Tyagi SC. FASEB J; 2014 Aug; 28(8):3411-22. PubMed ID: 24739303 [Abstract] [Full Text] [Related] Page: [Next] [New Search]